Heterogeneity of outcome with single-agent carfilzomib: all relapsed/refractory myelomas are not created equal
Year: 2013
Type: article
Source: Leukemia
DOI: 10.1038/leu.2013.161
Authors: S Z Usmani, A Hoering
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2077423709
